Thousands of people throughout the UK are dealing with a puzzling and severe skin disorder that has left the medical profession baffled. Sufferers experience their skin severely inflamed, cracked and peeling, frequently across their whole body, yet many doctors have trouble diagnosing or treating the condition. The occurrence, called topical steroid withdrawal (TSW) or red skin syndrome, has sparked unprecedented interest on online platforms, with videos documenting patients’ experiences accumulating over one billion views on TikTok alone. Although it affects a rising number of people, TSW is so little understood that some doctors and dermatologists doubt whether it exists at all. Now, in a first-of-its-kind move, researchers across the UK are undertaking a large-scale study to investigate what is responsible for these unexplained symptoms and reasons why some people develop the condition while others remain unaffected.
The Mysterious Illness Spreading Across the UK
Bethany Gamble’s experience exemplifies the devastating impact of topical steroid withdrawal on sufferers’ lives. The 21-year-old from Birmingham had managed her eczema well with steroid creams since childhood, but at eighteen, her condition worsened considerably. Her skin became intensely inflamed and red, splitting and weeping whilst the itching became what she refers to as “bone deep”. Within two years, the pain had become so intense that she was unable to leave her bed, requiring round-the-clock care from her mother. Most distressing of all, Bethany was repeatedly dismissed by medical professionals who blamed her symptoms on standard eczema and kept prescribing the very treatments she believed were causing her suffering.
The medical establishment remains divided on how to address TSW, with deep divisions about its basic nature. Some experts regard it as a debilitating allergic reaction to the topical steroids that represent the standard treatment for eczema across the NHS. Others maintain it amounts to a severe flare-up of existing skin conditions rather than a separate syndrome, whilst a handful doubt of its existence. This clinical uncertainty has placed patients like Bethany trapped in a diagnostic limbo, finding it hard to obtain suitable treatment. The lack of consensus has prompted Professor Sara Brown at the University of Edinburgh to establish the first major UK research project investigating TSW, funded by the National Eczema Society.
- Symptoms comprise severe inflammation, cracking skin and persistent pruritus throughout the body
- Patients describe “elephant skin” thickening and excessive flaking of keratinised cells
- Healthcare practitioners commonly disregard TSW as standard eczema or decline to recognise it
- The condition may become so debilitating that sufferers lack the capacity to carry out everyday tasks
Living with Steroid Topical Withdrawal
From Mild Eczema to Disabling Symptoms
For many patients, topical steroid withdrawal constitutes a catastrophic deterioration from a formerly stable dermatological condition. What starts with occasional itching in areas of skin fold can quickly progress into a widespread inflammatory reaction that renders patients unable to function. The transition often occurs abruptly, without warning, converting a manageable chronic condition into an acute medical crisis. Patients report their skin becoming impossibly hot, inflamed and red, with significant cracking and weeping that demands constant attention. The bodily burden is compounded by fatigue, as the persistent itching prevents sleep and healing, creating a destructive cycle of decline.
The rate at which TSW develops takes many sufferers off guard. Those who have lived with eczema for years, sometimes decades, are unprepared for the magnitude of symptoms that develop when their condition rapidly deteriorates. Simple daily activities become monumental challenges: showering becomes unbearable, dressing requires assistance, and preserving hygiene demands enormous effort. Some patients report feeling as though their skin is under assault from within, with inflammation spreading across their body in patterns that bear little resemblance to their past episodes. This dramatic transformation often drives sufferers to obtain emergency care, only to encounter disbelief from healthcare professionals.
The Push for Recognition
Perhaps the cruelest aspect of topical steroid withdrawal is the dismissive medical responses that commonly occurs with it. Patients experiencing serious, unexplained health issues are routinely told they simply have eczema flaring up, despite their assertion that this is essentially distinct from anything they’ve experienced before. Doctors often respond by prescribing stronger steroids or higher dosages, potentially worsening the very condition patients suspect the topical treatments triggered. This cycle of dismissal leaves sufferers experiencing abandonment by the healthcare system, compelled to manage their illness alone whilst being informed that their personal experience lacks validity. Many patients report feeling gaslit repeatedly, their concerns dismissed as anxiety or psychological rather than genuine physiological symptoms.
The absence of medical consensus has created a significant divide between patient experience and clinical acknowledgement. Without clear diagnostic criteria or defined treatment approaches, general practitioners and skin specialists find it difficult to diagnose TSW or provide suitable care. Some clinicians remain completely sceptical the condition exists, viewing all severe presentations as typical eczema or other known dermatological conditions. This clinical doubt results in diagnostic delays, unsuitable therapies and profound psychological distress for patients already suffering physically. The increased prominence of TSW on online platforms has highlighted this diagnostic void, encouraging investigation to investigate what thousands of people claim to be experiencing, even as the medical establishment continues to disagree on the appropriate response.
- Signs may develop suddenly in individuals with previously stable eczema treated by topical steroids
- Patients often face scepticism from healthcare professionals who ascribe worsening to standard eczema flares
- Medical professionals remain divided on whether TSW is a genuine condition or acute eczema flare-up
- Absence of diagnostic criteria means many sufferers find it difficult to obtain suitable care and assistance
- Social media has magnified voices of patients, with TSW hashtags reaching more than one billion views worldwide
Racial Disparities in Diagnosis and Care
The diagnostic complexities surrounding topical steroid withdrawal become increasingly evident amongst people with darker skin tones, where symptoms can be considerably more difficult to recognise visually. Erythema and inflammatory responses, the characteristic indicators of TSW in those with lighter complexions, manifest differently across various ethnicities, yet many assessment protocols remain focused on how the condition appears in white patients. This gap means that individuals from Black, Asian and minority ethnic backgrounds experiencing TSW often face even greater delays in identification and acceptance. Medical staff trained chiefly via presentations in lighter skin may fail to recognise the characteristic signs, leading to additional diagnostic errors and incorrect management approaches that can worsen symptoms.
Research into TSW has traditionally overlooked the lived experiences with darker complexions, perpetuating a cycle where their symptoms remain under-documented and under-studied. The social media conversations dominating TSW discussions have been predominantly influenced by voices with lighter skin, potentially skewing medical understanding and public awareness. As Professor Sara Brown’s pioneering British research progresses, ensuring diverse representation amongst participants will be essential to developing truly inclusive diagnostic frameworks and therapeutic strategies. Without intentional action to prioritise the perspectives of all ethnic groups, treatment inequalities in TSW identification and care threaten to increase, abandoning at-risk communities without adequate support or answers.
| Skin Tone | TSW Appearance |
|---|---|
| Light/Fair | Bright red inflammation, visible flushing and erythema across affected areas |
| Medium/Olive | Darker red or brownish discolouration with less pronounced visible redness |
| Dark/Deep | Purple-toned or ashen discolouration, with inflammation appearing as hyperpigmentation or hypopigmentation |
| Very Dark | Subtle changes in skin texture and tone, with inflammation manifesting as dark patches or loss of pigmentation |
Treatment and Research Solutions Coming to Light
Initial Major UK Investigation In Progress
Professor Sara Brown’s pioneering research at the University of Edinburgh marks a turning point for TSW sufferers seeking validation and clarity. Funded by the National Eczema Society, the study has enrolled hundreds of participants throughout the United Kingdom to explore the biological mechanisms underlying topical steroid withdrawal. By assessing symptoms, saliva samples and skin biopsies, researchers seek to identify why certain individuals exhibit TSW whilst others using identical steroid regimens do not. This detailed analysis marks a significant shift from dismissal to rigorous examination.
The study team partnering with Dr Alice Burleigh from patients’ support organisation Scratch That, brings both clinical expertise and firsthand experience to the study. Their joint methodology recognises that patients hold vital knowledge into their health situations. Professor Brown has identified patterns in TSW that cannot be accounted for by traditional understanding of eczema, including marked “elephant skin” thickening, extreme shedding and clearly defined inflammatory patches. The study results could substantially alter how healthcare practitioners manage diagnosis and treatment of this disabling illness.
Available Treatments and Their Limitations
Currently, treatment options for TSW continue to be limited and often unsatisfactory. Many clinicians persist in prescribing topical steroids despite evidence indicating they could worsen symptoms in susceptible individuals. Some patients describe short-term improvement from emollients, antihistamines and oral medications, though results vary widely. Dermatologists remain divided on best treatment approaches, with some supporting total steroid discontinuation whilst others advocate phased withdrawal. This shortage of unified guidance sees patients managing their care journeys predominantly by themselves, drawing substantially on peer support networks and digital communities for advice.
Psychological support and specialist dermatological care offer potential benefits, yet access remains patchy across the NHS. Some patients have explored alternative approaches including dietary modifications, environmental controls and holistic therapies, though scientific evidence validating such approaches is limited. The lack of established clinical protocols means treatment decisions often depend on individual dermatologist experience and patient preference rather than evidence-based guidelines. Until robust research yields conclusive findings, TSW sufferers frequently describe experiencing abandonment by conventional medicine.
- Emollients and moisturisers to support skin barrier function and decrease water loss
- Antihistamine medications to alleviate itching and associated sleep disruption during flare-ups
- Systemic corticosteroids or immune-suppressing agents for severe cases with specialist oversight
- Psychological counselling to manage trauma and anxiety related to chronic skin conditions
Testimonies of Aspiration and Perseverance
Despite the ambiguity regarding TSW and the frequently dismissive perspectives from healthcare professionals, patients are finding strength in community and shared experience. Digital support communities have become lifelines for those struggling with the condition, offering validation and practical advice when traditional medicine has let them down. Many individuals affected recount the moment they discovered the TSW hashtag as pivotal—finally finding others with identical symptoms and recognising they were not alone in their experience. This collective voice has been powerful enough to spark the first serious research efforts, showing that patient-led campaigns can advance medical understanding even when established institutions stay unconvinced.
Bethany Gamble and people in similar situations are committed to draw attention and campaign for due recognition of TSW within the medical establishment. Their willingness to recount personal stories of their difficulties on social media has made discussions more commonplace around a disorder that numerous physicians still refuse to acknowledge. These people are not waiting passively for responses; they are engaging in scientific investigations, documenting their symptoms thoroughly, and insisting that their accounts be treated with respect. Their resilience in the face of chronic suffering and medical gaslighting provides encouragement that answers may finally be within reach, and that those to come will obtain the validation and care they urgently require.
- Patient-led research initiatives are filling gaps overlooked by traditional medical institutions and accelerating understanding of TSW
- Online communities provide psychological assistance, actionable management techniques, and mutual recognition for affected individuals worldwide
- Advocacy efforts are gradually shifting medical perception, encouraging dermatologists to investigate rather than dismiss individual accounts
